Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
New medicines: human
Get the latest updates from New medicines: human directly as they happen.
Follow now 554 followers
Latest posts
Last updated 3 days ago
Human medicines European public assessment report (EPAR): Colchicine Agepha Pharma, colchicine, Status: Opinion
3 days ago
Human medicines European public assessment report (EPAR): Colchicine Agepha Pharma, colchicine, Status...
Human medicines European public assessment report (EPAR): Vislyfa, ranibizumab, Status: Opinion
3 days ago
Human medicines European public assessment report (EPAR): Vislyfa, ranibizumab, Status: Opinion
Human medicines European public assessment report (EPAR): Deqtynet, copper (64Cu) oxodotreotide, Status: Opinion
3 days ago
Human medicines European public assessment report (EPAR): Deqtynet, copper (64Cu) oxodotreotide, Status...
Human medicines European public assessment report (EPAR): Etcamah, camizestrant, Status: Opinion
3 days ago
Human medicines European public assessment report (EPAR): Etcamah, camizestrant, Status: Opinion
Human medicines European public assessment report (EPAR): Liraglutide STADA, liraglutide, Status: Opinion
3 days ago
Human medicines European public assessment report (EPAR): Liraglutide STADA, liraglutide, Status: Opinion
Human medicines European public assessment report (EPAR): Ablymico, liraglutide, Status: Opinion
3 days ago
Human medicines European public assessment report (EPAR): Ablymico, liraglutide, Status: Opinion
Human medicines European public assessment report (EPAR): Cenrifki, tolebrutinib, Status: Opinion
about 1 month ago
Human medicines European public assessment report (EPAR): Cenrifki, tolebrutinib, Status: Opinion
Human medicines European public assessment report (EPAR): Redemplo, plozasiran, Status: Opinion
about 1 month ago
Human medicines European public assessment report (EPAR): Redemplo, plozasiran, Status: Opinion
Human medicines European public assessment report (EPAR): Rexatilux, ranibizumab, Status: Opinion
about 1 month ago
Human medicines European public assessment report (EPAR): Rexatilux, ranibizumab, Status: Opinion
Human medicines European public assessment report (EPAR): Itvisma, onasemnogene abeparvovec, Status: Opinion
about 1 month ago
Human medicines European public assessment report (EPAR): Itvisma, onasemnogene abeparvovec, Status: Opinion
Human medicines European public assessment report (EPAR): Palbociclib Viatris, palbociclib, Status: Opinion
about 1 month ago
Human medicines European public assessment report (EPAR): Palbociclib Viatris, palbociclib, Status: Opinion
Human medicines European public assessment report (EPAR): Adstiladrin, nadofaragene firadenovec, Status: Opinion
about 2 months ago
Human medicines European public assessment report (EPAR): Adstiladrin, nadofaragene firadenovec, Status: Opinion